Libya vs Papua New Guinea: Reported cases of paralytic polio by world region
Libya
0 cases
in 2023
Papua New Guinea
0 cases
in 2023
Libya rank
26th
Papua New Guinea rank
26th
Reported cases of paralytic polio by world region over time
- Libya
- Papua New Guinea
How they compare
Libya currently reports 0 cases against 0 cases in Papua New Guinea, a difference of 0 cases.
The two have swapped places 5 times across 44 shared years of data; in 1980 it was Libya ahead.
Libya ranks 26th and Papua New Guinea ranks 26th of 199 countries.
Across the 5 decades both report, Libya averaged higher in 1 and Papua New Guinea in 1.
Head to head by decade
| Decade | Libya | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 34.3 cases | 15.6 cases | 18.7 cases | Libya |
| 1990s | 1.1 cases | 1.1 cases | 0 cases | — |
| 2000s | 0 cases | 0 cases | 0 cases | — |
| 2010s | 0 cases | 2.6 cases | 2.6 cases | Papua New Guinea |
| 2020s | 0 cases | 0 cases | 0 cases | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported cases of paralytic polio by world region, Libya or Papua New Guinea?
- Libya, at 0 cases against 0 cases in Papua New Guinea as of 2023.
- What is the difference in reported cases of paralytic polio by world region between Libya and Papua New Guinea?
- 0 cases, with Libya ahead.
- How many years of comparable data are there for Libya and Papua New Guinea?
- 44 years are reported by both, from 1980 to 2023.
- How do Libya and Papua New Guinea rank globally for reported cases of paralytic polio by world region?
- Libya ranks 26th and Papua New Guinea ranks 26th of 199 countries.
- Where does this data come from?
- World Health Organization (2019); World Health Organization (2024) – processed by Our World in Data, published as Reported cases of paralytic polio by world region. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Sum of wild poliovirus cases and circulating vaccine derived poliovirus cases.